Literature DB >> 24337442

TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.

Janet C Lindsey1, Ed C Schwalbe, Sandeep Potluri, Simon Bailey, Daniel Williamson, Steven C Clifford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337442      PMCID: PMC4313075          DOI: 10.1007/s00401-013-1225-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  11 in total

1.  TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.

Authors:  Hideyuki Arita; Yoshitaka Narita; Hirokazu Takami; Shintaro Fukushima; Yuko Matsushita; Akihiko Yoshida; Yasuji Miyakita; Makoto Ohno; Soichiro Shibui; Koichi Ichimura
Journal:  Acta Neuropathol       Date:  2013-10-31       Impact factor: 17.088

2.  DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.

Authors:  Edward C Schwalbe; Daniel Williamson; Janet C Lindsey; Dolores Hamilton; Sarra L Ryan; Hisham Megahed; Miklós Garami; Peter Hauser; Bożena Dembowska-Baginska; Danuta Perek; Paul A Northcott; Michael D Taylor; Roger E Taylor; David W Ellison; Simon Bailey; Steven C Clifford
Journal:  Acta Neuropathol       Date:  2013-01-05       Impact factor: 17.088

3.  Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

Authors:  Christian Koelsche; Felix Sahm; David Capper; David Reuss; Dominik Sturm; David T W Jones; Marcel Kool; Paul A Northcott; Benedikt Wiestler; Katja Böhmer; Jochen Meyer; Christian Mawrin; Christian Hartmann; Michel Mittelbronn; Michael Platten; Benjamin Brokinkel; Marcel Seiz; Christel Herold-Mende; Andreas Unterberg; Jens Schittenhelm; Michael Weller; Stefan Pfister; Wolfgang Wick; Andrey Korshunov; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2013-10-24       Impact factor: 17.088

4.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

5.  Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

Authors:  Pedro Castelo-Branco; Sanaa Choufani; Stephen Mack; Denis Gallagher; Cindy Zhang; Tatiana Lipman; Nataliya Zhukova; Erin J Walker; Dianna Martin; Diana Merino; Jonathan D Wasserman; Cynthia Elizabeth; Noa Alon; Libo Zhang; Volker Hovestadt; Marcel Kool; David T W Jones; Gelareh Zadeh; Sidney Croul; Cynthia Hawkins; Johann Hitzler; Jean C Y Wang; Sylvain Baruchel; Peter B Dirks; David Malkin; Stefan Pfister; Michael D Taylor; Rosanna Weksberg; Uri Tabori
Journal:  Lancet Oncol       Date:  2013-04-16       Impact factor: 41.316

6.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

Review 7.  Medulloblastomics: the end of the beginning.

Authors:  Paul A Northcott; David T W Jones; Marcel Kool; Giles W Robinson; Richard J Gilbertson; Yoon-Jae Cho; Scott L Pomeroy; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

8.  Molecular subgroups of medulloblastoma: the current consensus.

Authors:  Michael D Taylor; Paul A Northcott; Andrey Korshunov; Marc Remke; Yoon-Jae Cho; Steven C Clifford; Charles G Eberhart; D Williams Parsons; Stefan Rutkowski; Amar Gajjar; David W Ellison; Peter Lichter; Richard J Gilbertson; Scott L Pomeroy; Marcel Kool; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-12-02       Impact factor: 17.088

9.  TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.

Authors:  Marc Remke; Vijay Ramaswamy; John Peacock; David J H Shih; Christian Koelsche; Paul A Northcott; Nadia Hill; Florence M G Cavalli; Marcel Kool; Xin Wang; Stephen C Mack; Mark Barszczyk; A Sorana Morrissy; Xiaochong Wu; Sameer Agnihotri; Betty Luu; David T W Jones; Livia Garzia; Adrian M Dubuc; Nataliya Zhukova; Robert Vanner; Johan M Kros; Pim J French; Erwin G Van Meir; Rajeev Vibhakar; Karel Zitterbart; Jennifer A Chan; László Bognár; Almos Klekner; Boleslaw Lach; Shin Jung; Ali G Saad; Linda M Liau; Steffen Albrecht; Massimo Zollo; Michael K Cooper; Reid C Thompson; Oliver O Delattre; Franck Bourdeaut; François F Doz; Miklós Garami; Peter Hauser; Carlos G Carlotti; Timothy E Van Meter; Luca Massimi; Daniel Fults; Scott L Pomeroy; Toshiro Kumabe; Young Shin Ra; Jeffrey R Leonard; Samer K Elbabaa; Jaume Mora; Joshua B Rubin; Yoon-Jae Cho; Roger E McLendon; Darell D Bigner; Charles G Eberhart; Maryam Fouladi; Robert J Wechsler-Reya; Claudia C Faria; Sidney E Croul; Annie Huang; Eric Bouffet; Cynthia E Hawkins; Peter B Dirks; William A Weiss; Ulrich Schüller; Ian F Pollack; Stefan Rutkowski; David Meyronet; Anne Jouvet; Michelle Fèvre-Montange; Nada Jabado; Marta Perek-Polnik; Wieslawa A Grajkowska; Seung-Ki Kim; James T Rutka; David Malkin; Uri Tabori; Stefan M Pfister; Andrey Korshunov; Andreas von Deimling; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2013-10-31       Impact factor: 17.088

10.  Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.

Authors:  Volker Hovestadt; Marc Remke; Marcel Kool; Torsten Pietsch; Paul A Northcott; Roger Fischer; Florence M G Cavalli; Vijay Ramaswamy; Marc Zapatka; Guido Reifenberger; Stefan Rutkowski; Matthias Schick; Melanie Bewerunge-Hudler; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2013-05-14       Impact factor: 17.088

View more
  25 in total

Review 1.  The evolving molecular genetics of low-grade glioma.

Authors:  Sriram Venneti; Jason T Huse
Journal:  Adv Anat Pathol       Date:  2015-03       Impact factor: 3.875

2.  Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.

Authors:  Sven Lindner; Hagen S Bachmann; Andrea Odersky; Simon Schaefers; Ludger Klein-Hitpass; Barbara Hero; Matthias Fischer; Angelika Eggert; Alexander Schramm; Johannes H Schulte
Journal:  Biomed Rep       Date:  2015-05-13

Review 3.  The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.

Authors:  Julieann Lee; David A Solomon; Tarik Tihan
Journal:  J Neurooncol       Date:  2017-01-07       Impact factor: 4.130

4.  Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis.

Authors:  Seungjae Lee; Sumit Borah; Armita Bahrami
Journal:  J Mol Diagn       Date:  2017-03-09       Impact factor: 5.568

Review 5.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 6.  Epigenetic regulation in medulloblastoma.

Authors:  Jiaqing Yi; Jiang Wu
Journal:  Mol Cell Neurosci       Date:  2017-12-18       Impact factor: 4.314

Review 7.  Medulloblastoma epigenetics and the path to clinical innovation.

Authors:  Amanda R Haltom; Stephanie A Toll; Donghang Cheng; Shinji Maegawa; Vidya Gopalakrishnan; Soumen Khatua
Journal:  J Neurooncol       Date:  2020-08-20       Impact factor: 4.130

Review 8.  The molecular landscape of pediatric brain tumors in the next-generation sequencing era.

Authors:  Marlo R Firme; Marco A Marra
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

9.  Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.

Authors:  Josh Lewis Stern; Richard D Paucek; Franklin W Huang; Mahmoud Ghandi; Ronald Nwumeh; James C Costello; Thomas R Cech
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

Review 10.  Medulloblastomics revisited: biological and clinical insights from thousands of patients.

Authors:  Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott
Journal:  Nat Rev Cancer       Date:  2019-12-09       Impact factor: 69.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.